- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00675922
Study of the Treatment of Burn Wounds With Antimicrobial Topical Soaks (Soaks)
June 15, 2023 updated by: The University of Texas Medical Branch, Galveston
Comparing the Use of Sulfamylon 5%, Dakins 0.025%, Cerium, Silver Nitrate 5% and/or Other Topical Antimicrobial Products for the Treatment of Excised and/or Grafted Burn Wounds
Determine effectiveness of various antimicrobial solutions on burn wounds (infections, wound healing, length of hospital stay).
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Patients were treated with both Sulfamylon soaks and Silver nitrate soaks on different burn areas.
These two areas were then compared for incidence (percentage) of infections.
Study Type
Interventional
Enrollment (Actual)
98
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Galveston, Texas, United States, 77555
- University of Texas Medical Branch
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 day to 90 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Burn Injury requiring excisional therapy
- Hospitalization required until wounds are closed
Exclusion Criteria:
- Known hypersensitivity to products
- Outpatient treatment for burn injury
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Sulfamylon 5% and Silver Nitrate Soaks
Application of Sulfamylon 5% Solution and Silver Nitrate soaked dressings to two different burned area.
Sites were then monitored for infections during hospitalization.
|
Application of Sulfamylon and Silver Nitrate Solution to burn wound daily
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Infection Rate
Time Frame: Acute hospitalization following burn injury: admission to discharge (1-20 weeks)
|
Percent of infections following antimicrobial topical treatment with Sulfamylon vs Silver Nitrate Soaks.
|
Acute hospitalization following burn injury: admission to discharge (1-20 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Length of Hospital Stay With Various Antimicrobial Solutions for Burn Patients
Time Frame: Admission to burn unit to discharge
|
At the request of the study site, this study has been closed.
Access to study-related data is unavailable, and the PI is no longer at the institution.
Hence, we are unable to submit the results data for this outcome.
Although peer-reviewed articles have been located that reference NCT00675922 it is not clear and verifiable (without access to the actual study-related data) what the results for this outcome.
|
Admission to burn unit to discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: David N Herndon, MD, University of Texas
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 1995
Primary Completion (Actual)
May 1, 2008
Study Completion (Actual)
May 1, 2008
Study Registration Dates
First Submitted
December 26, 2007
First Submitted That Met QC Criteria
May 7, 2008
First Posted (Estimated)
May 12, 2008
Study Record Updates
Last Update Posted (Actual)
June 22, 2023
Last Update Submitted That Met QC Criteria
June 15, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 95-096
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Burn
-
Xequel Bio, Inc.United States Department of DefenseWithdrawnThermal Burn | Second Degree Burn
-
Indonesia UniversityRecruitingBurn Degree Second | Burn Degree ThirdIndonesia
-
XenoTherapeutics, Inc.Joseph M. Still Research Foundation, Inc.Active, not recruitingWound Heal | Thermal Burn | Burn Degree Second | Burns Degree Third | Burn (Disorder)United States
-
University Hospital Schleswig-HolsteinUniversity of LuebeckRecruitingSecond-degree Burn | Third-Degree BurnGermany
-
General Electric ResearchRecruitingBurn Wound | 2nd Degree Burn of the SkinUnited States
-
University Hospital, LinkoepingCompletedBurn Scar | Burns | Burn Second DegreeSweden
-
University of AlbertaRecruitingBurn Degree Second | Burn; Multiple Body Regions, Max. Second Degree | Third-Degree BurnCanada
-
S.K. Lerik General HospitalCompletedBurn Scar | Burns | Burn Degree Second | Electrical BurnIndonesia
-
Regenera Pharma LtdWithdrawnPartial Thickness Burn | Second Degree Burn Less Than 5%TBSAIsrael
-
First Affiliated Hospital, Sun Yat-Sen UniversityRecruiting
Clinical Trials on Sulfamylon 5% and Silver Nitrate Soaks
-
Shaheed Zulfiqar Ali Bhutto Medical UniversityCompletedUmbilical Granuloma
-
Wellspect HealthCareCompletedBacteriuriaUnited Kingdom
-
University of AarhusRanders Regional HospitalUnknown
-
The University of Hong KongCompletedEffectiveness of Dental Caries Arrest Treatment in Primary Teeth Using AgNO3 Followed by NaF VarnishEarly Childhood CariesChina
-
CareFusionCompletedMalignant Pleural EffusionUnited States, United Kingdom
-
Association of Dutch Burn CentresDutch Burns FoundationCompleted
-
University of Sao Paulo General HospitalUnknownMalignant Pleural EffusionBrazil
-
Jordi Gol i Gurina FoundationCompleted
-
GlaxoSmithKlineCompletedDentine HypersensitivityUnited States
-
Pernille PedersenCopenhagen University Hospital, HvidovreCompletedFetus or Newborn Affected by Condition of Umbilical CordDenmark